Clinical Trial Update: Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC [Phase 3]

View source ↗

Summary

Phase III trial assessing weekly versus tri-weekly schedules of a gemcitabine plus two taxanes combination in metastatic breast cancer; the study is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Breast Cancer (MBC) | Phase 3 | Status: COMPLETED | Results posted: 2011-09-27